SCHEDULE 13G/A: Long Focus Capital Management Discloses 6.0% Stake in Sight Sciences, Inc.
Beneficial Ownership Report (Schedule 13G Amendment)
Long Focus Capital Management, LLC and John Helmers have filed an amended Schedule 13G, reporting a 6.0% beneficial ownership stake in Sight Sciences, Inc. as of March 31, 2025.
Summary
- Long Focus Capital Management, LLC and John Helmers have jointly filed an Amendment No. 2 to Schedule 13G regarding their beneficial ownership in Sight Sciences, Inc.
- As of March 31, 2025, the reporting persons collectively beneficially own 3,126,508 shares of Sight Sciences, Inc. Common Stock.
- This ownership represents 6.0% of the total class of securities.
- Long Focus Capital Management, LLC, a Delaware limited liability company, is classified as an Investment Adviser (IA).
- John Helmers, a United States citizen, is classified as an Individual (IN) and controls Long Focus Capital Management, LLC.
- Both reporting persons hold shared voting power and shared dispositive power over all 3,126,508 shares.
- The securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing the control of the issuer.
- The shares are held on behalf of Long Focus Capital Management, LLC's clients, with no single client owning more than 5% of the class of securities.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing (Schedule 13G Amendment) disclosing beneficial ownership. It is neutral in tone and content, providing factual information about an investment firm's stake without commentary on the issuer's performance or outlook.
Future Outlook
NA
Industry Context
This filing is a routine disclosure of beneficial ownership by an investment firm, indicating a significant institutional stake in Sight Sciences, Inc. It does not provide specific insights into broader industry trends or competitive positioning, but rather reflects an investment decision within the medical device or ophthalmology sector where Sight Sciences operates.
Stakeholder Impact
- Shareholders: Provides transparency regarding a significant institutional investor's stake (6.0%), which can influence market perception and potentially signal confidence or interest in the company.
Key Dates
| Date | Description |
|---|---|
| 03/31/2025 | Date of event which requires the filing of this statement, representing the beneficial ownership as of the close of business on this date. |
| 05/15/2025 | Date the Schedule 13G Amendment No. 2 was signed and filed. |
Keywords
Sight Sciences, Long Focus Capital Management, John Helmers, Schedule 13G, Beneficial Ownership, Common Stock, Investment Adviser, SEC Filing, Institutional Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.